Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mukta Arora

Showing results (81-90 of 168) with videos related to

Pageof 17
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 17, 2020
Total Body Irradiation and Risk of Breast Cancer After Blood or Marrow Transplantation: A Blood or Marrow Transplantation Survivor Study ReportAndrew M McDonald, Yanjun Chen, Jessica Wu, et al.
Blood Advances|September 14, 2021
Nonrelapse mortality among patients diagnosed with chronic GVHD: an updated analysis from the Chronic GVHD ConsortiumZachariah DeFilipp, Amin M Alousi, Joseph A Pidala, et al.
Blood|July 28, 2011
Global and organ-specific chronic graft-versus-host disease severity according to the 2005 NIH Consensus CriteriaSally Arai, Madan Jagasia, Barry Storer, et al.
Haematologica|August 5, 2018
Diffuse alveolar hemorrhage is most often fatal and is affected by graft source, conditioning regimen toxicity, and engraftment kineticsFatma Keklik, Ezzideen Barjes Alrawi, Qing Cao, et al.
British Journal of Haematology|April 7, 2009
Prior rituximab correlates with less acute graft-versus-host disease and better survival in B-cell lymphoma patients who received allogeneic peripheral blood stem cell transplantationVoravit Ratanatharathorn, Brent Logan, Dan Wang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 20, 2009
HLA-identical sibling compared with 8/8 matched and mismatched unrelated donor bone marrow transplant for chronic phase chronic myeloid leukemiaMukta Arora, Daniel J Weisdorf, Stephen R Spellman, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 14, 2012
Poor agreement between clinician response ratings and calculated response measures in patients with chronic graft-versus-host diseaseJeanne M Palmer, Stephanie J Lee, Xiaoyu Chai, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 9, 2019
Hematopoietic Cell Transplant-Related Toxicities and Mortality in Frail RecipientsMerve Pamukcuoglu, Smita Bhatia, Daniel J Weisdorf, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 13, 2014
Impact of age on quality of life, functional status, and survival in patients with chronic graft-versus-host diseaseAreej El-Jawahri, Joseph Pidala, Yoshi Inamoto, et al.
JCI Insight|August 9, 2019
Stress responses, M2 macrophages, and a distinct microbial signature in fatal intestinal acute graft-versus-host diseaseShernan G Holtan, Ashraf Shabaneh, Brian C Betts, et al.
Pageof 17

Showing results (81-90 of 168) with videos related to

Sort By:
Pageof 17
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 17, 2020
Total Body Irradiation and Risk of Breast Cancer After Blood or Marrow Transplantation: A Blood or Marrow Transplantation Survivor Study ReportAndrew M McDonald, Yanjun Chen, Jessica Wu, et al.
Blood Advances|September 14, 2021
Nonrelapse mortality among patients diagnosed with chronic GVHD: an updated analysis from the Chronic GVHD ConsortiumZachariah DeFilipp, Amin M Alousi, Joseph A Pidala, et al.
Blood|July 28, 2011
Global and organ-specific chronic graft-versus-host disease severity according to the 2005 NIH Consensus CriteriaSally Arai, Madan Jagasia, Barry Storer, et al.
Haematologica|August 5, 2018
Diffuse alveolar hemorrhage is most often fatal and is affected by graft source, conditioning regimen toxicity, and engraftment kineticsFatma Keklik, Ezzideen Barjes Alrawi, Qing Cao, et al.
British Journal of Haematology|April 7, 2009
Prior rituximab correlates with less acute graft-versus-host disease and better survival in B-cell lymphoma patients who received allogeneic peripheral blood stem cell transplantationVoravit Ratanatharathorn, Brent Logan, Dan Wang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 20, 2009
HLA-identical sibling compared with 8/8 matched and mismatched unrelated donor bone marrow transplant for chronic phase chronic myeloid leukemiaMukta Arora, Daniel J Weisdorf, Stephen R Spellman, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 14, 2012
Poor agreement between clinician response ratings and calculated response measures in patients with chronic graft-versus-host diseaseJeanne M Palmer, Stephanie J Lee, Xiaoyu Chai, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 9, 2019
Hematopoietic Cell Transplant-Related Toxicities and Mortality in Frail RecipientsMerve Pamukcuoglu, Smita Bhatia, Daniel J Weisdorf, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 13, 2014
Impact of age on quality of life, functional status, and survival in patients with chronic graft-versus-host diseaseAreej El-Jawahri, Joseph Pidala, Yoshi Inamoto, et al.
JCI Insight|August 9, 2019
Stress responses, M2 macrophages, and a distinct microbial signature in fatal intestinal acute graft-versus-host diseaseShernan G Holtan, Ashraf Shabaneh, Brian C Betts, et al.
Pageof 17